Busque Philippe has filed 69 insider transactions across 1 company since March 2024.
Most recent transaction: a option exercise of 2049 shares of Cytek Biosciences, Inc. ($CTKB) on March 10, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2049 | $0.00 | 30,951.0000 | 127,604,317 | 7.09% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2946 | $0.00 | 17,682.0000 | 127,604,317 | 14.28% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2049 | $0.00 | 6,665.0000 | 127,604,317 | 23.51% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | A | Restricted Stock Units | 133226 | $0.00 | 133,226.0000 | 127,604,317 | 9999.99% | 0.10% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | A | Employee Stock Option (right to buy) | 70665 | $0.00 | 70,665.0000 | 127,604,317 | 9999.99% | 0.06% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 1496 | $4.23 | 35,687.0000 | 127,604,317 | 4.02% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 4833 | $0.00 | 37,183.0000 | 127,604,317 | 14.94% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 912 | $4.23 | 32,350.0000 | 127,604,317 | 2.74% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2946 | $0.00 | 33,262.0000 | 127,604,317 | 9.72% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 635 | $4.23 | 30,316.0000 | 127,604,317 | 2.05% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 4833 | $0.00 | 43,505.0000 | 127,604,317 | 10.00% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2210 | $0.00 | 20,628.0000 | 127,604,317 | 9.68% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 1536 | $0.00 | 8,714.0000 | 127,604,317 | 14.99% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 927 | $5.53 | 28,902.0000 | 127,604,317 | 3.11% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 3625 | $0.00 | 29,829.0000 | 127,604,317 | 13.83% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 565 | $5.53 | 26,204.0000 | 127,604,317 | 2.11% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2210 | $0.00 | 26,769.0000 | 127,604,317 | 9.00% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 393 | $5.53 | 24,559.0000 | 127,604,317 | 1.58% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 1536 | $0.00 | 24,952.0000 | 127,604,317 | 6.56% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 3625 | $0.00 | 48,338.0000 | 127,604,317 | 6.98% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 1536 | $0.00 | 20,453.0000 | 130,611,330 | 8.12% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 599 | $4.06 | 19,854.0000 | 130,611,330 | 2.93% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2210 | $0.00 | 22,064.0000 | 130,611,330 | 11.13% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 861 | $4.06 | 21,203.0000 | 130,611,330 | 3.90% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 3625 | $0.00 | 24,828.0000 | 130,611,330 | 17.10% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 1412 | $4.06 | 23,416.0000 | 130,611,330 | 5.69% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 1536 | $0.00 | 10,250.0000 | 130,611,330 | 13.03% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2210 | $0.00 | 22,838.0000 | 130,611,330 | 8.82% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 3625 | $0.00 | 51,963.0000 | 130,611,330 | 6.52% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 1024 | $0.00 | 11,786.0000 | 130,611,330 | 7.99% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2416 | $0.00 | 55,588.0000 | 130,611,330 | 4.17% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 1473 | $0.00 | 25,048.0000 | 130,611,330 | 5.55% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 1024 | $0.00 | 16,943.0000 | 130,611,330 | 6.43% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 399 | $2.69 | 16,544.0000 | 130,611,330 | 2.35% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 1473 | $0.00 | 18,017.0000 | 130,611,330 | 8.90% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 574 | $2.69 | 17,443.0000 | 130,611,330 | 3.19% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2416 | $0.00 | 19,859.0000 | 130,611,330 | 13.85% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 942 | $2.69 | 18,917.0000 | 130,611,330 | 4.74% | 0.00% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2049 | $0.00 | 12,810.0000 | 130,611,330 | 13.79% | 0.00% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 1148 | $4.36 | 15,919.0000 | 130,611,330 | 6.73% | 0.00% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2946 | $0.00 | 26,521.0000 | 130,611,330 | 10.00% | 0.00% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2049 | $0.00 | 14,920.0000 | 130,611,330 | 15.92% | 0.00% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 799 | $4.36 | 14,121.0000 | 130,611,330 | 5.36% | 0.00% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2946 | $0.00 | 17,067.0000 | 130,611,330 | 20.86% | 0.00% |
| March 4, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | A | Restricted Stock Units | 58004 | $0.00 | 58,004.0000 | 130,611,330 | 9999.99% | 0.04% |
| March 4, 2025 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | A | Employee Stock Option (right to buy) | 91911 | $0.00 | 91,911.0000 | 130,611,330 | 9999.99% | 0.07% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2210 | $0.00 | 13,732.0000 | 132,785,552 | 19.18% | 0.00% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 1536 | $0.00 | 14,859.0000 | 132,785,552 | 9.37% | 0.00% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2210 | $0.00 | 29,467.0000 | 132,785,552 | 6.98% | 0.00% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 861 | $6.03 | 12,871.0000 | 132,785,552 | 6.27% | 0.00% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 599 | $6.03 | 11,522.0000 | 132,785,552 | 4.94% | 0.00% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 1536 | $0.00 | 12,121.0000 | 132,785,552 | 14.51% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 599 | $5.53 | 9,236.0000 | 135,283,044 | 6.09% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 2210 | $0.00 | 11,446.0000 | 135,283,044 | 23.93% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 1536 | $0.00 | 16,395.0000 | 135,283,044 | 8.57% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 861 | $5.53 | 10,585.0000 | 135,283,044 | 7.52% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 1536 | $0.00 | 9,835.0000 | 135,283,044 | 18.51% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 2210 | $0.00 | 31,677.0000 | 135,283,044 | 6.52% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 1473 | $0.00 | 8,873.0000 | 135,283,044 | 19.91% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 1473 | $0.00 | 33,887.0000 | 135,283,044 | 4.17% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 6659 | $0.00 | 17,931.0000 | 135,283,044 | 27.08% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 574 | $5.96 | 8,299.0000 | 135,283,044 | 6.47% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 2594 | $5.96 | 7,400.0000 | 135,283,044 | 25.96% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 6659 | $0.00 | 9,994.0000 | 135,283,044 | 199.67% | 0.00% |
| March 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Common Stock | 5464 | $0.00 | 5,464.0000 | 135,283,044 | 9999.99% | 0.00% |
| March 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | F | Common Stock | 2129 | $6.70 | 3,335.0000 | 135,283,044 | 38.96% | 0.00% |
| March 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | M | Restricted Stock Units | 5464 | $0.00 | 0.0000 | 135,283,044 | 100.00% | 0.00% |
| March 6, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | A | Restricted Stock Units | 35360 | $0.00 | 35,360.0000 | 135,283,044 | 9999.99% | 0.03% |
| March 6, 2024 | Cytek Biosciences, Inc. | $CTKB | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | A | Employee Stock Option (right to buy) | 52631 | $0.00 | 52,631.0000 | 135,283,044 | 9999.99% | 0.04% |